Our Leadership Team
|
Charles Thompson, BBA, CPA
Chief Financial Officer Charlie has broad experience in pharmaceutical development and investment banking, including fundraising, mergers and acquisitions, investor relations, corporate governance and finance and accounting. He has been a consultant to Renexxion since May 2022.
Previously, Charlie was the Chief Financial Officer at Napo Pharmaceuticals, Inc. for over 14 years. Napo developed an FDA approved product for the symptomatic relief of diarrhea in adult HIV/AIDs patients on anti-retroviral therapy and completed an IPO on the London Stock Exchange. Napo had development partners in India, China and the US. He was responsible for all finance and accounting activities. He was also involved in the commercialization of Mytesiä, a FDA approved drug for HIV/AIDS diarrhea. Charlie was an investment banker with Roth Capital Partners and Sutro & Co. Incorporated in San Francisco. Mr. Thompson holds a BBA in Finance from the University of Oklahoma and is a Certified Public Accountant (inactive). |